Reflux1.com: Great Information, Real Community, Better Living.
 Register
 Login
 Main Page
 Reflux News
Feature Story
 Education Center
Conditions
Treatments
Diagnostics
 Living with GERD Center
 Pharmacology Center
Dr. Jamie Koufman  Reflux
 Hero™

Dr. Jamie Koufman:
Treating Reflux with Diet.
About Heroes
 Join the Discussion in  Our Forums
 Community
Reflux1 Forums
Patient Stories
Frequently Asked
   Questions
 Reference
Online Resources
Locate a Specialist
Video Library
advertisement
Search the Body1 Network
April 10, 2021  
HEARTBURN NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Heartburn Prescriptions on the Rise in Iowa

    Heartburn Prescriptions on the Rise in Iowa


    June 09, 2004

    By Rebecca Ostrom for Reflux1

    Iowans have increased their use of prescription heartburn medications by 35% over the last three years, according to a new report by Wellmark Blue Cross Blue Shield.

    Wellmark is Iowa’s largest health insurer and also offers health plans in South Dakota. In order to educate their clients about the high cost of prescription drugs, they publish a series of reports analyzing the use of different classes of prescription drugs. The most recent report details the increase in costs for prescription proton pump inhibitors (PPIs), including Nexium, Prevacid, Prilosec, and Protonix.

    South Dakota rates of prescription PPI use, unlike in Iowa, have only increased by 7% over the last three years. Nationwide, 78 patients out of 1,000 use PPIs. Both Iowa and South Dakota are below the nationwide rate, at 70 and 48 patients per 1,000.

    Wellmark’s summary of its analysis states, "In the last five years, PPI use by Wellmark members climbed 253 percent…." Furthermore, spending on PPIs increased by 325 percent, more than four times as much as in 1999.

    According to the Wellmark Report, there are a number of reasons why the use of prescription PPIs may have increased so drastically in recent years. The FCC loosened standards on advertising for prescription drugs. Drug companies have taken advantage of the decision and are advertising newer, more expensive, drugs, rather than their older medicines that may be as effective. Drug companies have increased their direct-to-consumer advertising by 35% between 1999 and 2002. All of these factors together mean that patients are more aware of the newer prescription options open to them. The advertising has also increased awareness about conditions that may have previously gone untreated.

    In addition, very few PPIs are available in a generic format. Of the top PPI medicines, only Prilosec (omeprazole) is available in a generic format. Only 17 percent of PPI prescriptions in Iowa and South Dakota were for the generic omeprazole. While most generic drugs are much cheaper than their prescription counterparts, omeprazole started out at nearly the same cost as brand name Prilosec. In 2004, the price has now dropped by one-third, although usually generics cost at least 40% less than their brand name counterparts.

    Although Wellmark does not criticize doctors for overprescribing expensive prescription drugs, the report does state that some patients may be served just as well by generic or over-the-counter medications. Antacids (including Tums and Rolaids) and H2 blockers (such as Pepcid and Zantac) can treat symptoms of heartburn. The report also suggests that patients may keep taking the prescription PPIs for longer than necessary.

    Last updated: 09-Jun-04

    Comments

  • Add Comment
  •    
    Interact on Reflux1

    Discuss this topic with others.
     
    Feature Archives
    Next 5 Features ...

    More Features ...
       
     
    Related Multimedia

    Interview with Dr. Foley: Heartburn

    Interview with Dr. Foley: Effective Medical Therapy for Heartburn

    Interview with Dr. Foley: Enteryx 1

    More Features ...
     
    Related Content
    Is Acid Reflux Disease Eating Away at You?

    From Crackers and Water to Pizza and Chocolate: A Reflux Survivor’s Story

    Which Direction to Turn with GERD

    From Acid Reflux to Esophageal Cancer – New Discovery Heralds Hope

    PPIs

    More Features ...
     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    © 2021 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.